EGFR/CDK2-IN-1

Modify Date: 2024-01-09 19:05:50

EGFR/CDK2-IN-1 Structure
EGFR/CDK2-IN-1 structure
Common Name EGFR/CDK2-IN-1
CAS Number 2841405-96-5 Molecular Weight 387.65
Density N/A Boiling Point N/A
Molecular Formula C19H12BrClO2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of EGFR/CDK2-IN-1


EGFR/CDK2-IN-1 (Compound 3b) is an EGFR/CDK2 inhibitor. EGFR/CDK2-IN-1 shows good cytotoxicity against MCF7 and HepG2 cells. EGFR/CDK2-IN-1 can be used in cancer research[1].

 Names

Name EGFR/CDK2-IN-1

 EGFR/CDK2-IN-1 Biological Activity

Description EGFR/CDK2-IN-1 (Compound 3b) is an EGFR/CDK2 inhibitor. EGFR/CDK2-IN-1 shows good cytotoxicity against MCF7 and HepG2 cells. EGFR/CDK2-IN-1 can be used in cancer research[1].
Related Catalog
Target

EGFR, CDK-2[1].

In Vitro EGFR/CDK2-IN-1 (0-20 μM; 48 h) shows excellent activity in both MCF7 and HepG2 with IC50 values of 4.1 and 3.5 μM, respectively[1]. Cell Cytotoxicity Assay[1] Cell Line: MCF7, HepG2 cells Concentration: 0-20 μM Incubation Time: 48 h Result: Exhibited good cytotoxic activity in breast and liver cancer cells.

 Chemical & Physical Properties

Molecular Formula C19H12BrClO2
Molecular Weight 387.65